Full history for every metric is available with a Kvantra account
Masimo Corporation (0JZ2.L)
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,144 | 1,239 | 2,036 | 2,048 | 2,094 | 1,527 | 1,559 |
| Operating profit | $m | 313 | 309 | |||||
| Net profit | $m | 240 | 230 | 144 | 82 | -305 | -151 | 76 |
| EPS reported | $ | -2.80 | 1.48 | |||||
| Operating cashflow per share | $ | 4.05 | 4.44 | |||||
| Capex per share | $ | 0.36 | 0.40 | |||||
| FCF per share | $ | 3.69 | 4.04 | |||||
| Free cash flow | $m | 198 | 211 | |||||
| Net debt | $m | 380 | 361 | |||||
| Book value equity | $m | 721 | 789 | |||||
| Book value per share | $ | 13.31 | 15.00 | |||||
| Number of shares | m | 54.2 | 52.6 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 9.69 | 12.09 | |||||
| P/S LTM | x | 4.58 | 6.12 | |||||
| P/FCF LTM | x | 35.34 | 45.22 | |||||
| EV/EBITDA LTM | x | 21.55 | 28.53 | |||||
| EV/Sales LTM | x | 4.74 | 6.35 | |||||
| Earnings Yield LTM | % | -2.22% | 0.80% | |||||
| FCF Yield | % | 2.83% | 2.21% | |||||
| Quality | ||||||||
| ROE | % | -21.01% | 8.98% | |||||
| ROIC | % | 17.76% | 18.28% | |||||
| Operating margin | % | 20.49% | 19.85% | |||||
| Gross margin | % | 61.90% | 61.73% | |||||
| FCF/Sales | % | 12.95% | 13.53% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -27.10% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | +12.13% | - | |||||
| Operating Profit Growth | % | +727.51% | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.35 | 0.43 | |||||
| Net Debt/EBITDA | x | 1.18 | 1.04 | |||||
| EBIT/Net interest | x | 9.42 | 10.11 | |||||
| Net debt/market cap | % | 5.44% | 3.79% | |||||
| Net debt/Equity | x | 0.53 | 0.46 | |||||
| Gross debt/equity | x | 0.78 | 0.62 | |||||
Company overview
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Masimo Corporation (0JZ2.L)
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free